We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients

By LabMedica International staff writers
Posted on 23 Jun 2025

Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota and altered concentrations of microbiome-related metabolites. More...

These metabolites have been associated with patient survival and could represent modifiable factors to improve outcomes. Now, researchers have developed a novel diagnostic tool—a metabolic dysbiosis score (MDS)—based on fecal metabolite profiling that can identify critically ill patients at higher risk of 30-day mortality.

The study, conducted by researchers at the University of Chicago (Chicago, IL, USA), aimed to uncover gut microbiome characteristics and metabolic signatures associated with mortality in patients admitted to the MICU for non–COVID–19 respiratory failure or shock. To develop the tool, the researchers performed a prospective observational cohort study involving 196 critically ill patients. Fecal specimens were collected shortly after ICU admission and analyzed using shotgun metagenomic sequencing to define microbiome composition, along with mass spectrometry to quantify microbiota-derived metabolites. The findings, published in Science Advances, show that individual metabolite levels and microbial compositions in the initial samples did not correlate directly with 30-day mortality

However, a specific combination of metabolite concentrations led to the creation of the MDS from fecal concentrations of 13 specific metabolites found in the first fecal sample after ICU admission. It showed a statistically significant independent association with 30-day mortality, offering a metabolic snapshot that could help clinicians identify patients at greater risk of poor outcomes. Importantly, this approach highlights the functional activity of the microbiome, beyond just taxonomic profiling. The MDS offers a new, non-invasive method to stratify critically ill patients based on their likelihood of survival. It opens the door for targeted interventions, such as microbiome-augmentation strategies, by identifying patients who might benefit most. The researchers suggest that fecal metabolic profiling could guide future clinical trials focused on improving outcomes through modulation of the gut microbiota.


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Combining rapid diagnostic tests with conventional serology proves to be a useful strategy for diagnosing Chagas disease (Courtesy of Adobe Stock)

Rapid Tests for Chagas Disease Improves Diagnostic Access

Chagas disease, caused by the parasite Trypanosoma cruzi, affects between six and seven million people across the Americas. It is primarily transmitted by insect vectors and remains largely underdiagnosed,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.